The global Digital Breast Tomosynthesis Equipment Market is estimated to be valued at US$ 2,400.6 Mn or Million in 2023 and is expected to exhibit a CAGR of 15. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Digital breast tomosynthesis equipment provides three-dimensional (3D) images of breast that helps doctors to accurately diagnose breast cancer. It is a revolutionizing technology that produces multiple X-ray breast images from different angles and uses computer algorithms to reconstruct them into 3D images. This improves detection of cancer and reduces chances of false positive results.
Market key trends:
One of the key trends in the digital breast tomosynthesis equipment market is replacement demand from upgraded technologies. Regular replacement of obsolete tomosynthesis equipment with newer breast cancer screening technologies leads to repeat sales and upgrades. While conventional 2D mammography systems have been standard for decades, new tomosynthesis models offer improved accuracy. This drives the need for replacement and upgrade of legacy 2D systems with advanced breast tomosynthesis solutions.
Segment Analysis:
The global digital breast tomosynthesis equipment market is segmented by product into standalone and integrated. The integrated segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. Integrated digital breast tomosynthesis equipment offers benefits such as lower cost of ownership and ease of use as compared to standalone equipment.
Key Takeaways:
The global digital breast tomosynthesis equipment market is expected to witness high growth, exhibiting a CAGR of 15% over the forecast period, due to increasing incidence of breast cancer and growing awareness regarding early detection.
Regional analysis:
North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period. High awareness regarding breast cancer screening and availability of favorable reimbursement policies in the region is driving the growth of the market.
Key players:
Major players operating in the global digital breast tomosynthesis equipment market size include Hologic, Inc., Internazionale Medico Scientifica-S.R.L, GE Healthcare, Siemens Healthineers, Fujifilm Corporation, Planmed OY, Trivitron Healthcare, Varex Imaging Corporation, and Analogic Corporation.
The global digital breast tomosynthesis equipment market size was valued at US$ 2,400.6 Mn in 2023 and is expected to reach over US$ 6,800 Mn by 2030, expanding at a CAGR of 15% during the forecast period.
No comments:
Post a Comment